Also from this source

You just read:

Stemline Therapeutics Receives Orphan Drug Designation for SL-401 for the Treatment of Acute Myeloid Leukemia

News provided by

Stemline Therapeutics, Inc.

Mar 09, 2011, 08:30 EST